Smilagenin Protects Dopaminergic Neurons in Chronic MPTP/Probenecid—Lesioned Parkinson’s Disease Models

Smilagenin Protects Dopaminergic Neurons in Chronic MPTP/Probenecid—Lesioned Parkinson’s Disease Models

Current therapies for Parkinson’s disease (PD) only offer limited symptomatic alleviation but fail to hamper the progress of the disease. Thus, it is imperative to establish new approaches aiming at protecting or reversing neurodegeneration in PD. Recent work elucidates whether smilagenin (abbreviat...

Full description

Bibliographic Details
Main Authors:	Xuan He, Shuangshuang Yang, Rui Zhang, Lina Hou, Jianrong Xu, Yaer Hu, Rang Xu, Hao Wang, Yongfang Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-02-01
Series:	Frontiers in Cellular Neuroscience
Subjects:	brain-derived neurotrophic factor Chinese herb dopaminergic neurons glial cell line-derived neurotrophic factor Parkinson’s disease
Online Access:	https://www.frontiersin.org/article/10.3389/fncel.2019.00018/full

Similar Items

Inhibition of Nigral Microglial Activation Reduces Age-Related Loss of Dopaminergic Neurons and Motor Deficits
by: Tzu-Feng Wang, et al.
Published: (2022-01-01)

Neurotrophic Factors in Parkinson’s Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain
by: Olesja Bondarenko, et al.
Published: (2021-06-01)

Mesencephalic astrocyte-derived neurotrophic factor: A treatment option for parkinson’s disease
by: Chun Yang, et al.
Published: (2020-06-01)

Neurotrophic factor-based strategies to enhance survival and differentiation of neural progenitor cells toward the dopaminergic phenotype
by: Stefano Di Santo, et al.
Published: (2018-01-01)

Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction
by: Xiaowei Tang, et al.
Published: (2019-08-01)

Growth/differentiation factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson's disease
by: Venissa Machado, et al.
Published: (2016-04-01)

Glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor regulate the interaction between astrocytes and Schwann cells at the trigeminal root entry zone
by: Madeha Ishag Adam, et al.
Published: (2023-01-01)

Encapsulated GDNF-producing C2C12 cells for Parkinson's disease: a pre-clinical study in chronic MPTP-treated baboons
by: Haruhiko Kishima, et al.
Published: (2004-07-01)

Prolonged survival and milder impairment of motor function in the SOD1 ALS mouse model devoid of fibroblast growth factor 2
by: Nadine Thau, et al.
Published: (2012-08-01)

Level of glial cell derived neurotrophic factor in the blood plasma of rheumatoid arthritis patients and its relationship with alexithymia
by: Yevhenii Shalkovskyi, et al.
Published: (2024-04-01)

Reduced serum neurotrophic factors and monoamine neurotransmitters in epilepsy patients with comorbid depression
by: Shulei Sun, et al.
Published: (2024-10-01)

Effect of Regular Aerobic Exercise on Cognitive Function, Depression Level and Regulative Role of Neurotrophic Factor: A Prospective Cohort Study in the Young and the Middle-Aged Sample
by: Kong L, et al.
Published: (2024-04-01)

The Influence of Neurotrophic Factors BDNF and GDNF Overexpression on the Functional State of Mice and Their Adaptation to Audiogenic Seizures
by: Angelina O. Kustova, et al.
Published: (2022-08-01)

Astroglial Mechanisms Underlying Chronic Insomnia Disorder: A Clinical Study
by: Zhang P, et al.
Published: (2020-10-01)

Transcranial alternating current stimulation rescues motor deficits in a mouse model of Parkinson's disease via the production of glial cell line-derived neurotrophic factor
by: Hong Ju Lee, et al.
Published: (2022-05-01)

GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-β for its neuroprotective action
by: Andreas Schober, et al.
Published: (2007-02-01)

Caloric Vestibular Stimulation Induced Enhancement of Behavior and Neurotrophic Factors in Chronic Mild Stress Induced Rats
by: Sherly Deborah George, et al.
Published: (2022-04-01)

GDNF to the rescue: GDNF delivery effects on motor neurons and nerves, and muscle re-innervation after peripheral nerve injuries
by: Alberto F Cintron-Colon, et al.
Published: (2022-01-01)

Histamine upregulates the expression of histamine receptors and increases the neuroprotective effect of astrocytes
by: Jiawen Xu, et al.
Published: (2018-02-01)

The Future of GDNF in Parkinson's Disease
by: Fredric P. Manfredsson, et al.
Published: (2020-12-01)

Molecular mechanisms underlying the neuroprotection of environmental enrichment in Parkinson’s disease
by: Tamara Andrea Alarcón, et al.
Published: (2023-01-01)

Enhanced computerized cognitive remediation therapy improved cognitive function, negative symptoms, and GDNF in male long-term inpatients with schizophrenia
by: Peiyun Zhang, et al.
Published: (2025-01-01)

Minocycline Enhance the Restorative Ability of Olfactory Ensheathing Cells by the Upregulation of BDNF and GDNF Expression After Spinal Cord Injury
by: Soheila Pourkhodadad, et al.
Published: (2021-11-01)

Electro-Acupuncture Ameliorated MPTP-Induced Parkinsonism in Mice via TrkB Neurotrophic Signaling
by: Yingke Zhao, et al.
Published: (2019-05-01)

Pretreated Glehnia littoralis Extract Prevents Neuronal Death Following Transient Global Cerebral Ischemia through Increases of Superoxide Dismutase 1 and Brain-derived Neurotrophic Factor Expressions in the Gerbil Hippocampal Cornu Ammonis 1 Area
by: Joon Ha Park, et al.
Published: (2017-01-01)

Circulating Levels of Glial Cell Line-Derived Neurotrophic Factor (GDNF) in Schizophrenia: a systematic review and meta-analysis
by: Omran Davarinejad, et al.
Published: (2025-01-01)

The effect of physical exercise on circulating brain‐derived neurotrophic factor in healthy subjects: A meta‐analysis of randomized controlled trials
by: Ya‐Hai Wang, et al.
Published: (2022-04-01)

Neurotrophic Factor Levels in Preterm Infants: A Systematic Review and Meta-Analysis
by: Francieli Cristina Krey, et al.
Published: (2021-04-01)

GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson’s disease
by: Xavier ed'Anglemont De Tassigny, et al.
Published: (2015-02-01)

Assessment of attention, memory, and salivary brain-derived neurotrophic factor in chronic smokers: A cross-sectional observational study
by: A Srividya, et al.
Published: (2023-01-01)

Mesencephalic astrocyte-derived neurotrophic factor (MANF) prevents the neuroinflammation induced dopaminergic neurodegeneration
by: Jing-Xing Zhang, et al.
Published: (2023-01-01)

Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease
by: Ali Sajadi, et al.
Published: (2006-04-01)

Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury
by: Anastasiia O. Sosnovtseva, et al.
Published: (2022-01-01)

Expression Analysis of BDNF Gene and BDNF-AS Long Noncoding RNA in Whole Blood Samples of Multiple Sclerosis Patients: Not Always a Negative Correlation between Them
by: Vajiheh Gharzi, et al.
Published: (2018-12-01)

Significant association of BDNF rs6265 G>A polymorphism with susceptibility to epilepsy: a meta-analysis
by: Xu Y, et al.
Published: (2018-04-01)

Neurotrophic factors-based therapeutic strategies in the spinal cord injury: an overview of recent preclinical studies in rodent models
by: Nazila Deznabi, et al.
Published: (2023-05-01)

Association of peripheral manifestation of brain‐derived neurotrophic factor with depression: A meta‐analysis
by: Sagun Tiwari, et al.
Published: (2022-06-01)

Brain Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor-Transfected Bone Mesenchymal Stem Cells for the Repair of Periphery Nerve Injury
by: Qiang Zhang, et al.
Published: (2020-07-01)

Local GDNF expression mediated by lentiviral vector protects facial nerve motoneurons but not spinal motoneurons in SOD1G93A transgenic mice
by: Sandrine Guillot, et al.
Published: (2004-06-01)

Functional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease
by: Mara Brizard, et al.
Published: (2006-01-01)